Guideline-Concordant Research Articles

The NLCRT will reduce lung cancer mortality through the assurance of guideline-concordant lung cancer staging and optimal diagnosis through comprehensive biomarker testing to position patients for appropriate and timely therapy and care.

Cover Sadigh State

Sadigh G, Gee Goeckner H, Kazerooni EA, Johnson BE, Smith RA, Adams DV, Carlos RC. State Legislative Trends Related to Biomarker Testing. CANCER (2022). DOI:

Fox AH, Smith RA, Jett J, Basu Roy U, Rosenthal LS, King J, Johnson BE, Osarogiagbon R, Rivera MP, Silvestri GA. Knowledge and Practice Patterns Among Pulmonologists for Molecular Biomarker Testing In Advanced Non-Small Cell Lung Cancer. CHEST (2021), DOI:

Henderson L, Farjah F, Detterbeck F, Smith RA, Silvestri GA, Rivera MP. Pretreatment Invasive Nodal Staging in Lung Cancer: Knowledge, Attitudes, and Beliefs among Academic and Community Physicians. CHEST (2021), DOI:

Mileham KF, Basu Roy U, Bruinooge S, Freeman-Daily J, Garon E, Garrett-Mayer E, Jalal S, Johnson BE, Moore A, Osarogiagbon R, Rosenthal LS, Schenkel C, Smith RA, Virani S, Weber Redman M, Silvestri GA. Defining comprehensive biomarker-related testing and treatment practices for advanced non-small-cell lung cancer: Results of a survey of U.S. oncologists. Cancer Medicine (2021), DOI:

Kim ES, Roy UB, Ersek JL, King J, Smith RA, Martin N, Martins R, Moore A, Silvestri GA, Jett J. Updates Regarding Biomarker Testing for Non-Small Cell Lung Cancer: Considerations from the National Lung Cancer Roundtable. J Thorac Oncol. 2019;14:338-42.

Cover Adige

Aldige C, Basu Roy U, Boerckel W, Ciupek A, Donaldson D, Grossman H, Langhorne C, Rosenthal LS, Saxton C, Silvestri GA, Smith RA, Wenger L. The Role of Lung Cancer Advocacy Organizations in Biomarker Testing. 2018. Available at:

Coming Soon Image

Fox AH, Nishino M, Osarogiagbon RU, Rivera MP, Rosenthal LS, Smith RA, Silvestri GA, Johnson BE. Acquiring Tissue for Lung Cancer Diagnosis and Comprehensive Biomarker Testing: A National Lung Cancer Roundtable Best Practice Guide. (submitted, CA: A Cancer Journal for Clinicians).